FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885121976> ?p ?o ?g. }

• W2885121976 endingPage "A34" @default.
• W2885121976 startingPage "A34" @default.
• W2885121976 abstract "Abstract Background: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumor of the GI tract. Most GISTs are driven by mutations in KIT or platelet-derived growth factor receptor-α (PDGFRA), which responds well to imatinib, a tyrosine kinase inhibitor (TKI) that blocks KIT and PDGFR-α signaling. Bcl-2 family plays a critical role in the regulation of cell apoptosis in GISTs. ABT-737 as an inhibitor of Bcl-2/Bcl-xL can result in a time- and dose-dependent activation of apoptosis. Autophagy is a key mechanism to promote tumor cells survival, inhibition of which can induce the cell death in GISTs. Chloroquine, an antimalarial drug, has been also identified as an autophagy inhibitor. In this study, we assessed the combinational effects of imatinib, ABT-737, and chloroquine in GIST cells. Methods: Human GIST cell lines, GIST-T1 and GIST-882, were employed in our study. Cells were treated with imatinib, ABT-737, and chloroquine either separately or in different combinations. Cell viability was tested by means of MTS and synergistic effects were analyzed by isobologram software. The levels of related proteins of apoptosis (PARP, Caspase-3) and autophagy (LC3-II, beclin-1) were measured by Western blot. Cell apoptosis and cell cycle were tested by flow cytometry. Results: Cell viability assay indicated that the cell survival percentage of double- or triple-drug combinations dramatically decreased (less than 5%) compared to that of single-drug treatment (42%, 36%, or 12%) (P&lt;0.05). Isobologram analysis revealed a strongly synergistic drug interaction, with combination indices (CI) &lt; 0.5 in most of double and triple combinations. Importantly, triple-drugs combination showed even more strongly synergistic effects compared to double-drugs combinations (CI =0.204 vs. 0.309 or 0.356, P&lt;0.05). Cell apoptosis assay showed that the cell apoptosis percentage of double- (32.9% or 36.6%) or triple-drugs combinations (66.5%) also significantly increased over that of single-drug treatments (6.1%, 6.1%, or 13.1%) (P&lt;0.05). Finally, Western blot discovered that double- or triple-drugs combinations increased the cleavage of PARP as well as expression of Caspase-3, but inhibited autophagy in comparison to single-drug treatments. Conclusions: The combination of imatinib, ABT-737, and chloroquine has collaborative effects on the treatment of GISTs in vitro. The combined strategy may enhance the clinical efficacy, which provides a rationale for the clinical evaluation of these drug combinations in GISTs treatment. Citation Format: Shuchao Zhang, Guozhi Hu, Ana cristina Paz-mejia, Luyuan Li, Jonathan C. Trent. Inhibition of autophagy sensitizes gastrointestinal stromal tumor cells to TKI/Bcl-2 inhibitors-induced apoptosis [abstract]. In: Proceedings of the AACR Conference on Advances in Sarcomas: From Basic Science to Clinical Translation; May 16-19, 2017; Philadelphia, PA. Philadelphia (PA): AACR; Clin Cancer Res 2018;24(2_Suppl):Abstract nr A34." @default.
• W2885121976 created "2018-08-22" @default.
• W2885121976 creator A5004418792 @default.
• W2885121976 creator A5018163640 @default.
• W2885121976 creator A5047029286 @default.
• W2885121976 creator A5050555673 @default.
• W2885121976 creator A5081147061 @default.
• W2885121976 date "2018-01-15" @default.
• W2885121976 modified "2023-09-27" @default.
• W2885121976 title "Abstract A34: Inhibition of autophagy sensitizes gastrointestinal stromal tumor cells to TKI/Bcl-2 inhibitors-induced apoptosis" @default.
• W2885121976 doi "https://doi.org/10.1158/1557-3265.sarcomas17-a34" @default.
• W2885121976 hasPublicationYear "2018" @default.
• W2885121976 type Work @default.
• W2885121976 sameAs 2885121976 @default.
• W2885121976 citedByCount "0" @default.
• W2885121976 crossrefType "journal-article" @default.
• W2885121976 hasAuthorship W2885121976A5004418792 @default.
• W2885121976 hasAuthorship W2885121976A5018163640 @default.
• W2885121976 hasAuthorship W2885121976A5047029286 @default.
• W2885121976 hasAuthorship W2885121976A5050555673 @default.
• W2885121976 hasAuthorship W2885121976A5081147061 @default.
• W2885121976 hasConcept C121608353 @default.
• W2885121976 hasConcept C126322002 @default.
• W2885121976 hasConcept C16930146 @default.
• W2885121976 hasConcept C190283241 @default.
• W2885121976 hasConcept C203522944 @default.
• W2885121976 hasConcept C2775922572 @default.
• W2885121976 hasConcept C2777583451 @default.
• W2885121976 hasConcept C2778729363 @default.
• W2885121976 hasConcept C2778820342 @default.
• W2885121976 hasConcept C29537977 @default.
• W2885121976 hasConcept C31573885 @default.
• W2885121976 hasConcept C502942594 @default.
• W2885121976 hasConcept C53227056 @default.
• W2885121976 hasConcept C54355233 @default.
• W2885121976 hasConcept C55493867 @default.
• W2885121976 hasConcept C62112901 @default.
• W2885121976 hasConcept C71924100 @default.
• W2885121976 hasConcept C86803240 @default.
• W2885121976 hasConcept C98274493 @default.
• W2885121976 hasConceptScore W2885121976C121608353 @default.
• W2885121976 hasConceptScore W2885121976C126322002 @default.
• W2885121976 hasConceptScore W2885121976C16930146 @default.
• W2885121976 hasConceptScore W2885121976C190283241 @default.
• W2885121976 hasConceptScore W2885121976C203522944 @default.
• W2885121976 hasConceptScore W2885121976C2775922572 @default.
• W2885121976 hasConceptScore W2885121976C2777583451 @default.
• W2885121976 hasConceptScore W2885121976C2778729363 @default.
• W2885121976 hasConceptScore W2885121976C2778820342 @default.
• W2885121976 hasConceptScore W2885121976C29537977 @default.
• W2885121976 hasConceptScore W2885121976C31573885 @default.
• W2885121976 hasConceptScore W2885121976C502942594 @default.
• W2885121976 hasConceptScore W2885121976C53227056 @default.
• W2885121976 hasConceptScore W2885121976C54355233 @default.
• W2885121976 hasConceptScore W2885121976C55493867 @default.
• W2885121976 hasConceptScore W2885121976C62112901 @default.
• W2885121976 hasConceptScore W2885121976C71924100 @default.
• W2885121976 hasConceptScore W2885121976C86803240 @default.
• W2885121976 hasConceptScore W2885121976C98274493 @default.
• W2885121976 hasIssue "2_Supplement" @default.
• W2885121976 hasLocation W28851219761 @default.
• W2885121976 hasOpenAccess W2885121976 @default.
• W2885121976 hasPrimaryLocation W28851219761 @default.
• W2885121976 hasRelatedWork W1968814687 @default.
• W2885121976 hasRelatedWork W2009307226 @default.
• W2885121976 hasRelatedWork W2355246966 @default.
• W2885121976 hasRelatedWork W2394906198 @default.
• W2885121976 hasRelatedWork W2410520497 @default.
• W2885121976 hasRelatedWork W2741236739 @default.
• W2885121976 hasRelatedWork W2966033854 @default.
• W2885121976 hasRelatedWork W4361824095 @default.
• W2885121976 hasRelatedWork W4386326336 @default.
• W2885121976 hasRelatedWork W3127233814 @default.
• W2885121976 hasVolume "24" @default.
• W2885121976 isParatext "false" @default.
• W2885121976 isRetracted "false" @default.
• W2885121976 magId "2885121976" @default.
• W2885121976 workType "article" @default.